PNC Financial Services Group’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

PNC Financial Services Group’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-200	Closed	-$2K	–	4673
2016 Q2	$2K	Hold	200	–	–	﹤0.01%	4313
2016 Q1	$2K	Hold	200	–	–	﹤0.01%	4318
2015 Q4	$5K	Hold	200	–	–	﹤0.01%	3914
2015 Q3	$3K	Hold	200	–	–	﹤0.01%	4229
2015 Q2	$5K	Hold	200	–	–	﹤0.01%	4132
2015 Q1	$5K	Buy	+200	New	+$5.07K	﹤0.01%	4061

Other funds holding OMED

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PNC Financial Services Group's OMED Position: Q3 2016 in Review

PNC Financial Services Group sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q3 2016, closing a stake of 200 shares — an estimated $2K sold.

PNC Financial Services Group first reported a position in OMED in Q1 2015 and held it in 6 quarters. The position peaked at $5K in Q4 2015. 89 funds tracked by Wall St. Rank hold OMED as of Q3 2016.

PNC Financial Services Group reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
PNC Financial Services Group sold 200 OncoMed Pharmaceuticals, Inc. shares in Q3 2016, an estimated $2K.
PNC Financial Services Group first reported a position in OncoMed Pharmaceuticals, Inc. in Q1 2015 and held it in 6 quarters.
PNC Financial Services Group's OncoMed Pharmaceuticals, Inc. position peaked at $5K in Q4 2015.
89 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q3 2016.

Based on PNC Financial Services Group's 13F filing for Q3 2016, filed 4 Nov 2016.